From professional translators, enterprises, web pages and freely available translation repositories.
sibutramine
liite iii
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
sibutramine treatment.
itsemurha- ajatuksia ja itsemurhia.
Last Update: 2012-04-10
Usage Frequency: 2
Quality:
sibutramine should not be used during pregnancy.
sibutramiiniä ei pidä käyttää raskauden aikana.
Last Update: 2012-04-10
Usage Frequency: 2
Quality:
have shown no evidence of drug abuse with sibutramine.
lisääntymisestä ei kuitenkaan ole näyttöä sibutramiinin yhteydessä.
Last Update: 2012-04-10
Usage Frequency: 2
Quality:
sibutramine containing medicinal products with marketing authorisation in iceland
hoito tulee keskeyttää potilailla, joilla ei ole saatu riittävää vastetta 15 mg: n vahvuudella (painonlasku on alle 2 kg neljässä (4) hoitoviikossa).
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: Contains invisible HTML formatting
Warning: This alignment may be wrong.
Please delete it you feel so.
early administration of activated charcoal may delay the absorption of sibutramine.
lääkehiilen anto varhaisvaiheessa voi viivyttää sibutramiinin imeytymistä.
Last Update: 2012-04-10
Usage Frequency: 2
Quality:
however, clinical data show no evidence of an increased incidence with sibutramine.
tietoa ei ole saatavilla sibutramiinin hoidosta potilailla, joilla on pakonomainen syömishäiriö (syöpöttelykausia).
Last Update: 2012-04-10
Usage Frequency: 2
Quality:
two weeks should elapse between stopping sibutramine and starting monoamine oxidase inhibitors.
sibutramiinin käytön lopettamisesta mao- estäjien käytön aloittamiseen on kuluttava kaksi viikkoa.
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
- increased plasma levels have been observed in the assessment of sibutramine in patients with
- valmistetta tulee käyttää varoen potilailla, joilla on lievä tai kohtalainen munuaisten vajaatoiminta.
Last Update: 2012-04-10
Usage Frequency: 2
Quality:
sibutramine is an anti-obesity agent which inhibits the reuptake of norepinephrine and serotonine.
4. 3 vasta- aiheet
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
favourable improvements of the lipid profile and the glycaemic control with the use of sibutramine can be shown.
- tiedossa oleva yliherkkyys sibutramiinihydrokloridimonohydraatille tai jollekin muulle
Last Update: 2012-04-10
Usage Frequency: 2
Quality:
in vitro hepatic microsome studies indicated that cyp3a4 is the major cytochrome p450 isoenzyme responsible for sibutramine metabolism.
on monien lääkkeiden farmakokineettisiin yhteisvaikutuksiin osallistuva pienikapasiteettinen entsyymi.
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
calcitonins human coagulation factor viii loratadine sibutramine gatifloxacin nimesulide cox-2-inhibitors:
human coagulation factor viii loratadine sibutramine gatifloxacin
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
no data are available for sibutramine in the treatment of patients with binge (compulsive) eating disorder.
suurentunut riski silmäpaineen kohoamiseen, esim. sukurasite.
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
further in vitro studies have revealed that sibutramine has no significant effect on the activity of the major p450 isoenzymes, including cyp3a4.
metaboliitti 2: n jatkometaboliaan osallistuvat cyp450- entsyymit olivat (in vitro) cyp3a4 ja cyp2c9.
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
if signs or symptoms of depression occur during the treatment with sibutramine, the discontinuation of sibutramine and commencement of an appropriate treatment should be considered.
jos sibutramiinihoidon aikana havaitaan masennuksen merkkejä tai oireita, on sibutramiinin käytön lopettamista ja asianmukaisen hoidon aloittamista harkittava.
Last Update: 2012-04-10
Usage Frequency: 2
Quality:
sibutramine and its active metabolites are eliminated by hepatic metabolism; the main enzyme involved is cyp3a4, and cyp2c9 and cyp1a2 can also contribute.
tärkein siihen osallistuva entsyymi on cyp3a4, ja myös cyp2c9 ja cyp1a2 voivat osallistua.
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
this suspension was mainly due to safety concerns, based on a number of reports of serious adverse reactions associated with sibutramine in italian patients, including two fatal cases.
oheinen valmisteyhteenveto oli sibutramiinia sisältäviä lääkkeitä käsittelevän 31 artiklan mukaista tutkimuspyyntöä koskevan komission päätöksen liitteenä.
Last Update: 2012-04-10
Usage Frequency: 2
Quality:
cpmp/ 4514/ 02/ final - sibutramine should be given with caution to are at risk of raised intraocular pressure,
emea 2003 cpmp/ 4514/ 02/ final - kuten muidenkin serotoniinin takaisinottoa
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
3 nifedipine slow release, sibutramine or alcohol have been observed.the absence of these interactions has been demonstrated in specific drug-drug-interaction studies.
3 ei interaktioita erityisissä yhteisvaikutustutkimuksissa ei ole todettu interaktioita amitriptyliinin, atorvastatiinin, biguanidien, digoksiinin, fibraattien, fluoksetiinin, losartaanin, fenytoiinin, fentermiinin, pravastatiinin, nifedipiinin gts: n (gastrointestinaalinen terapeuttinen järjestelmä) , pitkävaikutteisen nifedipiinivalmisteen, sibutramiinin eikä alkoholin kanssa.
Last Update: 2008-03-04
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.